These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Arginine flux and nitric oxide production during human pregnancy and postpartum.
    Author: Goodrum LA, Saade GR, Belfort MA, Moise KJ, Jahoor F.
    Journal: J Soc Gynecol Investig; 2003 Oct; 10(7):400-5. PubMed ID: 14519480.
    Abstract:
    OBJECTIVE: To compare second-trimester, third-trimester, and postpartum arginine flux and nitric oxide production using infusions of the stable isotope L-[(15)N(2)]-arginine in normal human gestation. METHODS: Kinetic measurements were made in pregnant volunteers with uncomplicated singleton gestations in mid gestation, late gestation, and more than 8 weeks postpartum. A bolus of 4.95 micromol/kg of labeled arginine was administered, followed by an infusion at 4.95 micromol/kg per hour for 6 hours. The isotopic enrichment of plasma arginine and nitrite or nitrate (NO(x)) was determined by gas chromatography, mass spectrometry, or both. We used the Kolmogorov-Smirnov test for normality, repeated-measures analysis of variance, and Newman-Keuls test. P <.05 denoted statistical significance. RESULTS: The rate of turnover of the intravascular NO(x) pool was significantly higher in mid gestation compared with late gestation and almost reached statistical significance when compared with postpartum values (6.2 +/- 0.9 versus 4.3 +/- 0.8 [P <.02] versus 3.7 +/- 2.1% pool/hour; P =.08). Arginine flux was significantly higher in early compared with late gestation and postpartum (107.8 +/- 13.9 versus 72.5 +/- 16.1 versus 82 +/- 8.8 micromol/kg per hour, respectively; P <.01). CONCLUSION: Arginine and nitric oxide production is higher in mid gestation. This suggests a role for nitric oxide in early cardiovascular adaptation in human gestations.
    [Abstract] [Full Text] [Related] [New Search]